Inspirna Raises $50 Million in Series D Financing
NEW YORK--(Business enterprise WIRE)--Inspirna, Inc., a scientific stage biopharmaceutical company establishing initial-in-course smaller molecule therapeutics, announced that it has lifted $50 million in a Series...